Bowe enters new battle with Prostate Cancer fight
Gulf Western Oil Touring Car Masters champion John Bowe has confirmed that he has been diagnosed with Prostate Cancer.
The five-time TCM series winner has encouraged all men over 40 to be tested for the disease, after posting the news on his public Facebook profile on Sunday night.
CLICK HERE to read Bowe’s original Facebook post.
Bowe has long been a vocal advocate for men’s health, both physical and mental, in the more recent years of his glittering career.
As well as his remarkable run of TCM success, his CV also includes a pair of Bathurst 1000 victories, two 12-Hour wins, the 1995 Australian Touring Car Championship and a pair of Gold Star awards.
Bowe is also a member of the Australian Motorsport Hall of Fame.
“Remember a while ago I encouraged all men over 40 to get yearly check ups regarding Prostate Cancer? Well guess what?? I have been, and have now been confirmed to have it,” Bowe wrote.
“I feel fine and have no signs, but it’s there and I must do something about it! So don’t put it off just because you don’t feel any symptoms.”
Bowe will receive his first treatment this week but has vowed to race at the second round of the series at Mount Panorama ‘come hell or high water’ in three weeks time.
“I’m having my first treatment on Tuesday at the new Peter McCallum Cancer Clinic in North Melbourne. After that I’m not sure because there are several options,” he wrote.
“As our Touring Car Masters season continues at Bathurst in a few weeks time, I’m unsure of what effect it will have on that, but I’ll be racing at the Mountain come hell or high water!!
“I’ve never been one to pass up an opportunity to drive at that amazing racetrack!!”
Bowe recently notched up his 100th TCM race victory and leads the 2020 championship following the opening round at Symmons Plains.
The next round is scheduled for Mount Panorama, Bathurst, on February 26-28.
We wish JB the very best in his upcoming battle and joins him in urging all men over the age of 40 to be tested once yearly for Prostate Cancer.